Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Cases and Controversies in HIV: ART and Pregnancy

Listen to José R. Arribas, MD; Andrew Carr, MBBS, MD, FRACP, FRCPA; and Lynora Saxinger, MD, FRCPC, CTropMed, discuss a patient case highlighting ART safety and management in a woman who wishes to conceive.
José R. Arribas, MD
Andrew Carr, MBBS, MD, FRACP, FRCPA
Lynora Saxinger, MD, FRCPC, CTropMed
Released: April 26, 2021

In this episode, Drs José R. Arribas, Andrew Carr, and Lynora Saxinger discuss ART safety and management in a woman who wishes to conceive.

Presenters:

José R. Arribas, MD
Research Director, HIV and Infectious Diseases
Hospital La Paz IdiPAZ
Madrid, Spain

Andrew Carr, MBBS, MD, FRACP, FRCPA
Professor of Medicine
University of New South Wales
Director, HIV and Immunology Unit
St Vincent’s Hospital
Sydney, Australia

Lynora Saxinger, MD, FRCPC, CTropMed
Cochair, Scientific Advisory Group
Alberta COVID-19 Emergency
Coordination Centre
Associate Professor
Division of Infectious Diseases
Department of Medicine
University of Alberta
Edmonton, Alberta
Canada

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Gilead Sciences, Inc.

Related Content

Dr Milena Murray and Clinical Care Options (CCO): Current pharmacokinetic and safety data support the use of tenofovir alafenamide during pregnancy

person default Milena Murray, PharmD, MSc, BCIDP, AAHIVP Released: September 15, 2021

Dr Jason Halperin and Clinical Care Options (CCO): Rapid ART in adolescents leads to virologic suppression and upholds equity

Jason Halperin, MD, MPH Released: September 10, 2021

Dr Jason Halperin and Clinical Care Options (CCO): Medication treatment for OUD improves HIV viral suppression rates

Jason Halperin, MD, MPH Released: September 10, 2021

Clinical Care Options (CCO): adolescent describes the relief he felt when rapidly initiated on ART and the importance of U=U in his decision to start ART

person default Anonymous Patient Released: September 7, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue